Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I hear you loud and clear, CC is trying anyway to get from the past dealings, he just picked the wrong horse to back on this one. Like I have been questioning why isn't one of the companies CC & Doctor tossed up as partners ? Why havent one of them up the offer especially when we were told 100B over the next 10 years is just waiting to be put on the world stage. That at the time put our SP @ 3.00+ no factor put on the value. So why hasn't a single one been talked about for the past year or better? Thoses are easy questions for CC or the Doctor to answer? For the one that always says you should send them something , I have , and even offered a million to promote their science in return for a different class of restricted stock, Crickets. GLTA
They need the value to be present in some form , or the stock price will drop. We can't break .05 you think it will hold 11.00?
I hear you , I think if CC walked other SPAC's would look at SAGA as the reason enough information out there of their ineffectiveness. Matter of time now either they get it done or NASDAQ will give them the boot. I really don't think they have raised the first 250m they offered and surely not the 450m. GLTA
It is a non bidding agreement both can walk away anytime.
Latest filing of Enzolytics vs Kona
71. Letter to the Honorable Richard G. Andrews from Attorneys for Plaintiff, Defendant regarding requesting teleconference with the Court re: Joint Revised Scheduling Order - re [63] Order, Terminate Deadlines and Hearings. (filed: 09/14/2023)
Funny a few post back I was talking about him and tweets and 20 minutes later we get one . Can't make this stuff up
rookie you can honor them with the reward of the day.
I think it would be more the Good DR that posted many things the SEC would take notice to if a complaint was filed. Elon was fined with a tweet that proposed going private. You never know what will happen if ENZC fails to deliver. Alot was posted with claims and as a officer of the company is a problem.
Musk tweeted on Aug. 24, 2018 that Tesla would remain public. A month later, he agreed to pay a $20 million civil fine to settle fraud charges by the U.S. Securities and Exchange Commission.
GLTA
Well with them adding that 900m to the A/S awhile back, maybe they planned on needing money to bailout SAGA to make this deal happen. SAGA has been on notice from NASDAQ for awhile. Who knows what the reason we will be given , if any. The other thing SAGA aka Barry said they were going to give an update and more details of the deal that hasn't happened either.
The real question and only question as of right now that Enzolytics owes shareholders is a real reason for the multiple delays in Africa we are now 3.5 months behind when they said it was to start. If you really look at the timeline the good Dr. posted along with Enzolytics in 2021 Africa testing was coming, then 2023 start dates were given and have seens pasted. WHY??? If this ITV-1 and Clone 3 showed the results they have claimed why hasnt a BP isn't stepping up to buyout to have in their toolchest, they already see what has been offered and that would be a drop in the bucket to double or even triple that offer. Either to proceed with it or shelf it to keep the money coming in for them either way a win win for them, not patients.
Why doesnt Samsung and or Intel step up and work the same deal for Enzolytic to selloff the 2 sub companies they both have the money to do that without having to raise funds? Just alittle weird that the two companies that wrote that they were amazed by Enzolytics techknowledge isn't stepping up to make it reality.
I am long , and not bashing just raising a few questions that questions what we have been told but yet to see results on a grand scale. GLTA
That was the amount approx of the Dimitar Savov case against the transfer company and ENZC thoses shares were already issued so I dont think they would have come from the A/S .
Hopefully it is and their investors have seen enough over the past 2 years and pull the money. GLTA
All most 3 million dollars , maybe they are preparing to go alone and get the testing starting. Has to be a reason CC and the doctor haven't sold or converted their ENZC shares. GLTA
Here is the outline of the SPAC and deadline of Oct 23 2023 it has failed with closing 2 deals so far
Conditions to the Parties’ Obligations to Consummate the Merger
Under the Business Combination Agreement, the obligations of the parties to consummate (or cause to be consummated) the Transactions are subject to a number of customary conditions for special purpose acquisition companies, including, among others, the following: (i) all specified approvals or consents (including foreign or domestic governmental and regulatory approvals) and all waiting or other periods have been obtained or have expired or been terminated, as applicable, (ii) the Written Consent, the PubCo Shareholder Consent and the PubCo Merger Sub Stockholder Consent shall have been delivered to Sagaliam, (iii) the Sagaliam Proposals shall have been approved and adopted by the requisite affirmative vote of the stockholders of Sagaliam, (iv) the shares of PubCo Ordinary Shares to be issued in connection with the Transactions, shall have been approved for listing on Nasdaq or another national securities exchange mutually agreed upon by the Parties, as of the Closing Date, (v) no Governmental Authority shall have enacted any Law or rule which has the effect of making the Transactions illegal or otherwise prohibiting the consummation of the Transactions, (vi) the Sagaliam Certificate of Incorporation shall have been amended as contemplated by the Certificate Amendment, which provides that the date by which Sagaliam must consummate its initial business combination (the “Business Combination Deadline”) may be extended for up to ten (10) successive one month periods up to October 23, 2023 by the deposit by Sponsor of additional funds into the trust account at each extension election, (vii) the Registration Statement / Proxy Statement shall have been declared effective, (viii) Sagaliam shall have at least $5,000,001 of net tangible assets immediately after the Merger Effective Time, after giving effect to the Transactions, (ix) on the Closing Date, immediately prior to the Share Exchange, the PLC Conversion shall have become effective, and the shareholder(s) of PubCo shall have amended and restated the memorandum of association and articles of association, and (x) Seller and PubCo shall have entered into the Lock-Up Agreement.
Here is link or you can look at all of 8K on file.
https://www.sec.gov/Archives/edgar/data/1855351/000149315222032641/form8-k.htm
https://trellis.law/case/36087/032620-2023/gld-principal-strategies-llc-v-barry-kostiner
Hoping for the best , but as your post shows nothing since 2020 , nothing from SAGA and nothing from his other managed company he is involved with. We really only have another month and a half for this to happen, then the SPAC is done. It has been extended to the limit at that point the 2 year limit is up at that point. GLTA
https://marketrealist.com/p/spacs-that-failed/
According to a report by Skadden, Arps, Slate, Meagher & Flom LLP, the slowdown in SPAC activity is expected to continue for the remainder of 2023 for a variety of reasons. First, interest rates and inflation remain high and investors continue to prefer lower risk investments over higher risk growth companies 1.
The report also highlights that in 2023, as of the end of Q1 2023, only 11 SPAC IPOs were filed and 40 de-SPAC transactions were completed. As a result, the SPAC market looks considerably different in 2023 than it did in 2021 1.
It remains to be seen whether SPACs will continue to offer companies a viable path to go public when compared to a traditional IPO 1.
Learn more:
1. skadden.com
2. bcg.com
All great points Timing , the one that stands out is they have all this background in SAGA but have yet to close a deal now for 2.5 years, and IMO the trend will continue. They also have a 1 million dollar fee to pay to AE because that deal didn't close. We can not over look their value of 11+ for what no product , no deals , and how many investors have pulled their money out recently. GLTA
Not deep enough ,
According to the search results, Sagaliam Acquisition Corp. has not yet completed a deal.
A business combination agreement is a legal document for when companies merge that determines who has voting power for specific issue, such as amendments to the company's bylaws and mergers with other companies. Unfortunately, many business owners are unaware of the importance of a business combination agreement.
This is what I am finding when researching the meaning
I guess the question is what is keeping the SAGA SP holding with nothing completed for two years and late on nasdaq filings. With no news out of Africa before the deal is to be completed what do you think will happen to the SAGA sp when they release 45 million shares with still no products , no revenune, and late on extentions still and deliquient on NASDAQ. Does anyone think it will hold 10+ dollars , if the deal is signed and completed using the deadline they have to meet and no news out of Africa.
Hoping for the best , preparing for a long winter GLTA
29 or anyone else out there wants to weigh in on why SAGA SP is at 11+ dollars , no product , no closing of deals , deliquent with NASDAQ. SPAC's have lost their luster and have not faired well over the past year. With August ending we will not see any results from Africa this year, unless they have started the trials and just not saying anything and will drop news after the fact. Who knows at this point , I would rather the deal isn't completed and Enzolytics countinues doing what they do.
As other and I have said , the news and claims that Enzolytics have disclosed other companies, investors, and BP should be all over this so what is going on? GLTA
Gotcha
MP this is what I typed in and the answer
when converting restricted share to unrestrict or common shares does it increase the outstanding share
When converting restricted shares to unrestricted or common shares, it does not increase the outstanding shares. Restricted shares are the shares outstanding reserved for employees and insiders. These shares cannot be traded freely. But they can become unrestricted under certain conditions. These conditions are up to the company so they vary
Wonder if this is the consultor
Kelly Austin PhD, PPM - Regulatory Specialist - LinkedIn
Explore this image
WebKelly Austin PhD, PPM Regulatory Specialist I Help Companies Receive FDA Orphan Drug (ODD), Pediatric Rare Disease, Fast Track, Breakthrough …
I hear you but if they bought above .20 they can buy at .04, knowing they will double up plus average lower a win win. GLTA
As it stands as of today , if they start the jab on Monday we will have to wait til Dec 15 or later to see the full results . So IMO asking a realist question does SAGA roll the dice and close the deal or is Enzolytics going to go it solo until the results are shown? GLTA not bashing just hoping for the best either way. My concern is why isn't the volume here knowing if the deal goes thru you are doubling your money due to the dividend? GLTA have a great weekend
another update , seems all going in a circle. You will need to sign up if you want to view the entire history , if you use the link the code will come to me not you. I see 19 have tried to use the code request they have been coming to me .
https://www.docketbird.com/court-cases/Enzolytics-Inc-v-Kona-Concepts-Inc/ded-1:2021-cv-01600?utm_source=frozen_email&utm_medium=email&utm_campaign=np_public_user_following&utm_content=following&db_uid=c83c9bb9-0982-437a-8c42-479d243c6538
Sagaliam Acquisition Corp. has three different trading symbols because it has three different classes of warrants. The first class of warrants is traded under the symbol SAGAW, the second class of warrants is traded under the symbol SAGAZ, and the third class of warrants is traded under the symbol SAGAU 1.
MP just asking your take on the 200m if they just became unrestricted wouldn't you think they would hold on to them after hearing the dividend deal that is in the works? They have been holding for awhile like alot of us here what is a few more months ?
That is from the first trial we are asking for the results from the trial they are making reference to that was being paid for by the partner and was underway . I am done
Have a great night
You are having issues understanding what people are asking about. I would like you to bring the cheese to the club and hand it to me.
What do you think people are confused on? We have been waiting for the start of Africa for awhile now. As the example I posted they were already redoing the trial in the EU and people are questing where the results are from the 2nd trial. Now Enzolytics are saying they will use data from Africa and start a trial in EU 2023/2024. We all have read what was stated.
CLINICAL RESULTS AND NEW TRIALS
The therapy has been tested already in a clinical setting in the EU, but due to interference with costs in manufacturing and a lack of financing, the clinical trial couldn’t be completed. However, they do have data, and this data will show investors how the current clinical trial should readout.
Now that the Bulgarian Drug Administration (BGA) has been supplanted by the European Medicines Agency (EMA), the company is conducting a trial under EMA guidelines. This is great for Enzolytics because approval of ITV-1 under the EMA can lead to FDA approval due to the EU Recognition Treaty. And, this time, the clinical trial should be completed because Enzolytics has already secured a partner: Partnership International Medical Partners, Ltd. (IMPL), which is a 50/50 joint venture between Enzolytics and Bulgarian principals. Enzolytics is producing the ITV-1, while the other party is funding the clinical trials.
here is the article
https://insiderfinancial.com/enzolytics-enzc-takes-on-hiv-heavyweight-gilead-sciences/181723/#:~:text=Now%20that%20the%20Bulgarian%20Drug%20Administration%20%28BGA%29%20has,FDA%20approval%20due%20to%20the%20EU%20Recognition%20Treaty
This is from July
Read I said invest in the PIPE
I guess I am missing something this is from the 1st link I posted earlier . This is what a few here are questioning where are the results . Per statement June 26 2021. Now they are saying after Africa. Anyone is welcome to explain how this and what they are saying now is confusing and over 2 years old and no results. This is what DD finds
CLINICAL RESULTS AND NEW TRIALS
The therapy has been tested already in a clinical setting in the EU, but due to interference with costs in manufacturing and a lack of financing, the clinical trial couldn’t be completed. However, they do have data, and this data will show investors how the current clinical trial should readout.
Now that the Bulgarian Drug Administration (BGA) has been supplanted by the European Medicines Agency (EMA), the company is conducting a trial under EMA guidelines. This is great for Enzolytics because approval of ITV-1 under the EMA can lead to FDA approval due to the EU Recognition Treaty. And, this time, the clinical trial should be completed because Enzolytics has already secured a partner: Partnership International Medical Partners, Ltd. (IMPL), which is a 50/50 joint venture between Enzolytics and Bulgarian principals. Enzolytics is producing the ITV-1, while the other party is funding the clinical trials.
BM I have been here long enough to recall you needing to be led by the hand everytime something was posted by the company asking for help with research because of one reason or the other , so please stop while you are ahead.
Yes I have written Enzolytics yes they recieved and havent written a reply. I have written SAGA asking about how to invest in the PIPE and details about it, that has gone unanswered to.
If anyone is investing in any stock by the words only posted on any message board then they have bigger issues. You would read the boards do your own DD and then invest. Clearly if someone does DD on Enzolytics over the past 2.5 years they will see confusing comments and missed opportunities by the company, that is a fact you or anyone else can look up.
Have a great day , not going to go back and forth with you . Again you can look up whatever you want for the past 2.5 years and see for yourself what has been printed by Enzolytics.
GF if you are out there , can you please explain the issues that Enzolytics keeps having on meeting timeframe set by them, requirements that are needed to execute said progress. Noone can blame the country of Africa on this, this lays with Enzolytics lack of execution, poor planning and lack of readiness.I would llike to hear your take on one requirement missed after the other? You have a good take on everything positive but don't comment on the negative issues that Enzolytics creates for themselves.
All the company owners on this board are you impressed with how they are always blindsided by requirements needed to take the next step forward? I am sure before any of you started your business you looked into everything you could before starting forward. At what point would you give up trying to do this by yourself and hire a firm that knows the in and outs of the Bio field trial procedures, or maybe ask Samsung above anyone for some advice. GLTA
Here are just a few examples of what we were told and what has happened here. Their is reason to question what actually is going on here. First example says they are doing EMA trials look at the date. In 2023 they have labeling issues, insurance issues now they don't understand exporting regulations in the 11th hour. They thought they would just import a new drug into the country with no documentation really? I would say any of the companies they are working with for production of ITV-1 would have said hey if you are shipping into XYZ location you will need to do ABC before it is allowed to enter area.
Now you see the reason SAGA filed and will keep filing extentions. Do you really think the companies that are being approached to invest in a 450m deal doesn't go back and have staff looking into Enzolytics history. As any of us here can look at their past posting and timelines they set and see they did not meet and the reasons for not doing so. Yes the shareholders have a reason to be frustrated, pissed off or any other negative feeling they might have due to the lack of attention to detail being displayed by the Manangement of Enzolytics. They have had two years to develope a plan in Africa and figure out everything needed that is facts not speculation. Funding for EMA trials was secured
https://insiderfinancial.com/enzolytics-enzc-takes-on-hiv-heavyweight-gilead-sciences/181723/#:~:text=Now%20that%20the%20Bulgarian%20Drug%20Administration%20%28BGA%29%20has,FDA%20approval%20due%20to%20the%20EU%20Recognition%20Treaty.
https://finance.yahoo.com/news/enzolytics-inc-wholly-owned-subsidiary-113000423.html
https://finance.yahoo.com/news/enzolytics-inc-finalizing-regulatory-labeling-110000405.html
I am long but I do feel as if we have all been lied to with misstatements of what is actually happening according to their own timeframes. GLTA